Morphine Extended-Release Capsules and Moxetumomab pasudotox
Determining the interaction of Morphine Extended-Release Capsules and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Moxetumomab Pasudotox-tdfk
- Morphine Extended-Release Capsules-Moxetumomab pasudotox-tdfk Intravenous
- Morphine Extended-Release Capsules-Moxifloxacin
- Morphine Extended-Release Capsules-Moxifloxacin (Systemic)
- Morphine Extended-Release Capsules-Moxifloxacin Hydrochloride
- Morphine Extended-Release Capsules-Moxifloxacin Injection
- Moxetumomab pasudotox-Morphine Immediate-Release Tablets and Capsules
- Moxetumomab pasudotox-Morphine injection
- Moxetumomab pasudotox-Morphine Injection PF
- Moxetumomab pasudotox-Morphine Long-Acting Tablets
- Moxetumomab pasudotox-Morphine Oral Concentrate (20 mg/mL)
- Moxetumomab pasudotox-Morphine Oral Solution